A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

NCT07455045 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

High Grade Glioma (III or IV)
Diffuse Midline Glioma (DMG)
Glioblastoma (GBM)

Interventions

DRUG: FZ-AD005

Sponsor

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.